-
1Academic Journal
المؤلفون: A. G. Chuchalin, Z. R. Aysanov, A. S. Belevskiy, A. Yu. Bushmanov, O. S. Vasil'eva, I. K. Volkov, N. A. Geppe, N. P. Knyazheskaya, N. N. Mazitova, N. N. Meshcheryakova, N. M. Nenasheva, V. A. Revyakina, I. V. Shubin, А. Г. Чучалин, З. Р. Айсанов, А. С. Белевский, А. Ю. Бушманов, О. С. Васильева, И. К. Волков, Н. А. Геппе, Н. П. Княжеская, Н. Н. Мазитова, Н. Н. Мещерякова, Н. М. Ненашева, В. А. Ревякина, И. В. Шубин
المصدر: PULMONOLOGIYA; № 2 (2014); 11-32 ; Пульмонология; № 2 (2014); 11-32 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2014-0-2
مصطلحات موضوعية: контроль над астмой, bronchial hyperresponsivenes, management, asthma control, бронхиальная гиперреактивность, лечение
وصف الملف: application/pdf
Relation: https://journal.pulmonology.ru/pulm/article/view/234/233; https://journal.pulmonology.ru/pulm/article/view/234
-
2Academic Journal
المؤلفون: A. F. Abubikirov, A. S. Belevsky, N. P. Knyazheskaya, N. A. Kuzubova, L. A. Mazaeva, O. N. Titova, А. Ф. Абубикиров, А. С. Белевский, Н. П. Княжеская, Н. А. Кузубова, Л. А. Мазаева, О. Н. Титова
المصدر: PULMONOLOGIYA; № 1 (2013); 42-48 ; Пульмонология; № 1 (2013); 42-48 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2013-0-1
مصطلحات موضوعية: контроль над астмой, M–cholinolytics, β2–agonists, inhaled steroids, asthma control, М–холинолитики, β2–агонисты, ингаляционные глюкокортикостероиды
وصف الملف: application/pdf
Relation: https://journal.pulmonology.ru/pulm/article/view/43/42; Чучалин А.Г. (ред.). Глобальная стратегия лечения и профилактики бронхиальной астмы. М.: Атмосфера; 2007. 53–54.; Княжеская Н.П. Короткодействующий бронхолитик Беродуал в лечении бронхиальной астмы и хронической обструктивной болезни легких. Справочник поликлин. врача 2010; 5: 42–45.; Цой А.Н., Архипов В.В. Вопросы клинической фармакологии β2–адреностимуляторов. Рус. мед. журн. 2001; 9 (21): 930–933.; Dolovich M.B., Ahrens R.C., Hess D.R. et al. Device selection and outcomes of aerosol therapy: Evidence based guidelines: American College of Chest Physicians / American Collegeof Asthma, Allergy, and Immunology. Chest 2005;127: 335–371.; Fink J.B., Rubin B.K. Problems with Inhaler Use: a call for improved clinican and patient education. Respir. Care 2005; 50 (10): 1360–1374.; Машковский М.Д. Лекарственные средства. 15–е изд. М.: ООО "Новая волна"; 2007.; Авдеев С.Н. Роль антихолинергических препаратов при обструктивных заболеваниях легких. Consilium Medicum 2002; 4 (9): 42–46.; Rodrigo G.J., Rodrigo C. First–line therapy for adult patients with acute asthma receiving a multiple–dose protocol of ipratropium bromide plus albuterol in the emergency department. Am. J. Respir. Crit. Care Med. 2000; 161 (6):1862–1868.; Шмелев Е.И. Тиотропий в лечении бронхиальной астмы. Атмосфера. Пульмонол. и аллергол. 2008; 1: 18–22.; Чучалин А.Г. Тяжелая бронхиальная астма. Рус. мед. журн. 2000; 8; 12 (113): 482–486.; Федосеев Г.Б., Трофимов В.И. Бронхиальная астма.СПб.: Нордмед; 2006.; Molfino N.A., Slutsky A.S., Julia–Serda G. et al. Assessment of airway tone in asthma. Am. Rev. Respir. Dis. 1993; 148: 1238–1243.; Barnes P.J. Modulation of neurotransmission in airways. Physiol. Rev. 1992; 72: 699–729.; Ayala L.E., Ahmed T. Is there loss of protective muscarinic receptor mechanism in asthma? Chest 1989; 96: 1285–1291.; Kanazawa H., Kawaguchi T., Shoji S. et al. Synergistic effect of nitric oxide and vasoactive intestinal peptide on bronchoprotection against histamine in anesthetized guinea pigs. Am. J. Respir. Crit. Care Med. 1997; 155: 747–750.; Israel E., Chinchilli V.M., Ford J.G. et al. Use of regulatory scheduled albuterol treatment in asthma: genotype–statified, randomized, placebo–controlled cross–over trial. Lancet 2004; 23: 1505–1512.; Rodrigo G., Rodrigo C., Burschtin O. A meta–analysis of the effect of ipratropium bromide in adults with acute asthma. Am. J. Med. 1999; 107: 363–370.; Hallstrand T.S., Fahy J. Practical management of acute asthma in adults. Respir. Care 2002; 47: 171–182.; https://journal.pulmonology.ru/pulm/article/view/43
-
3Academic Journal
المؤلفون: S. N. Avdeev, С. Н. Авдеев
المصدر: PULMONOLOGIYA; № 2 (2011); 93-99 ; Пульмонология; № 2 (2011); 93-99 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2011-0-2
مصطلحات موضوعية: asthma control, ACQ questionnaire, контроль над астмой, опросник ACQ
وصف الملف: application/pdf
Relation: https://journal.pulmonology.ru/pulm/article/view/310/308; Bateman E.D., Hurd S.S., Barnes P.J. et al. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 2008; 31: 143–78.; Weiss K.B., Sullivan S.D., Lyttle C.S. Trends in the cost of illness for asthma in the United States, 1985–1994. J. Allergy Clin. Immunol. 2000; 106: 493–499.; Fuhlbrigge A.L., Adams R.J., Guilbert T.W. et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am. J. Respir. Crit.Care Med. 2002; 166: 1044–1049.; Lai C.K., De Guia T.S., Kim Y.Y. et al. Asthma control in the Asia Pacific region: the Asthma Insights and Reality in Asia Pacific Study. J. Allergy Clin. Immunol. 2003; 111:263–268.; Rabe K.F., Vermeire P.A., Soriano J.B., Maier W.C. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur. Respir. J. 2000; 16:802–807.; Expert Panel Report 3 (EPR 3): Guidelines for the Diagnosis and Management of Asthma Summary Report 2007.J. Allergy Clin. Immunol. 2007; 120: S94–S138.; British Thoracic Society and Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline, 2008.; Global Initiative for Asthma. Global strategy for asthma management and prevention. Available from www.ginasthma.org. Date last updated, 2002.; Global Initiative for Asthma. Global strategy for asthma management and prevention. Available from www.ginasthma.org. Date last updated, 2006.; Global Initiative for Asthma. Global strategy for asthma management and prevention. Available from www.ginasthma.org. Date last updated, 2009.; Graham L.M. Classifying asthma. Chest 2006; 130:13S–20S.; Calhoun W.J., Sutton L.B., Emmett A. et al. Asthma variability in patients previously treated with 2-agonists alone.J. Clin. Immunol. 2003; 112: 1088–1094.; Fuhlbrigge A.L. Asthma severity and asthma control: symptoms, pulmonary function, and inflammatory markers.Curr. Opin. Pulm. Med. 2004; 10: 1–6.; Reddel H.K., Taylor D.R., Bateman E.D. et al. An official American Thoracic Society / European Respiratory Society Statement: asthma control and exacerbations standardizing endpoints for clinical asthma trials and clinical practice.Am. J. Respir. Crit Care Med. 2009; 180: 59–99.; Asthma in America: a landmark survey. GlaxoSmithKline,1998. Available at: http://www.asthmainamerica.com; Kuehni C.E., Frey U. Age related differences in perceived asthma control in childhood: guidelines and reality. Eur.Respir. J. 2002; 20: 880–889.; Juniper E.F., O'Byrne P.M., Guyatt G.H. et al. Development and validation of a questionnaire to measure asthma control. Eur. Respir. J. 1999; 14: 902–907.; Nathan R.A., Sorkness C.A., Kosinski M. et al. Development of the asthma control test: a survey for assessing asthma control. J. Allergy Clin. Immunol. 2004; 113: 59–65.; Vollmer W.M., Markson L.E., O'Connor E. et al. Association of asthma control with health care utilization and quality of life. Am. J. Respir. Crit Care Med. 1999; 160: 1647–1652.; Boulet L.-P., Boulet V., Milot J. How should we quantify asthma control? A proposal. Chest 2002; 122: 2217–2223.; Bateman E.D., Bousquet J., Braunstein G.L. Is overall asthma control being achieved? A hypothesis-generating study.Eur. Respir. J. 2001; 17: 589–595.; Ehrs P.-O., Nokela M., Stallberg B. et al. Brief questionnaires for patient-reported outcomes in asthma: validation and usefulness in a primary care setting. Chest 2006; 129:925–932.; Bateman E.D., Boushey H.A., Bousquet J. et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am. J. Respir. Crit Care Med. 2004; 170: 836–844.; Белевский А.С. Тест контроля астмы – "новая игрушка"или важный инструмент? Атмосфера. Пульмонология и аллергология 2005; 1: 1–2.; Огородова Л.М., Деев И.А., Селиванова П.А. GINA 2006:Контроль астмы как основная цель лечения и критерий эффективности терапии. Пульмонология 2007; 6:42–45.; Peters S.P., Jones C.A., Haselkorn T. et al. Real-world Evaluation of Asthma Control and Treatment (REACT):findings from a national Web based survey. J. Allergy Clin.Immunol. 2007; 119: 1454–1461.; Kosinski M., Kite A., Yang M. et al. Comparability of the Asthma Control Test telephone interview administration format with self administered mail-out mai- back format.Curr. Med. Res. Opin. 2009; 25: 717–727.; Schatz M., Sorkness C.A., Li J.T. et al. Asthma Control Test:reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J. Allergy Clin.Immunol. 2006; 117: 549–556.; Schatz M., Mosen D.M., Kosinski M., et al. Validity of the Asthma Control Test completed at home. Am. J. Manag.Care 2007; 13: 661–667.; Thomas M., Kay S., Pike J. et al. The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey.Prim. Care Respir. J. 2009; 18: 41–49.; Juniper E.F., O'Byrne P.M., Roberts J.N. Measuring asthma control in group studies: do we need airway calibre and rescue β2-agonist use? Respir. Med. 2001; 95: 319–323.; Svensson K., Mork A.C., Juniper E.F. ACQ – is five out of seven items acceptable in large clinical studies? Qual. Life Res. 2003; 12: 771.; Juniper E.F., Svensson K., Mork A.C. et al. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir. Med. 2005; 99:553–558.; Juniper E.F., Bousquet J., Abetz L. et al. Identifying ''well-controlled'' and ''not well controlled'' asthma using the Asthma Control Questionnaire. Respir. Med. 2006; 100:616–621.; Bousquet J., Boulet L.P., Peters M.J. et al. Budesonide / for-moterol for maintenance and relief in uncontrolled asthma vs high dose salmeterol / fluticasone. Respir. Med. 2007;101: 2437–2446.; Kuna P., Peters M.J., Manjra A.I. et al. Effect of budesonide /formoterol maintenance and reliever therapy on asthma exacerbations. Int. J. Clin. Pract. 2007; 61: 725–736.; Rabe K.F., Atienza T., Magyar P. et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006; 368: 744–753.; O'Byrne P.M., Reddel H.K., Eriksson G. et al. Measuring asthma control: a comparison of three classification systems. Eur. Respir. J. 2010; 36: 269–276.; Lange P., Parner J., Vestbo J. et al. A 15 year follow up study of ventilatory function in adults with asthma. N. Engl. J.Med. 1998; 339: 1194–1200.; Bateman E.D., Reddel H.K., Ericksson G. et al. Overall asthma control: the relationship between current control and future risk. J. Allergy Clin. Immunol. 2010; 125: 600–608.; Scicchitano R., Aalbers R., Ukena D. et al. Efficacy and safety of budesonide / formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.Curr. Med. Res. Opin. 2004; 20: 1403–1418.; O'Byrne P.M., Bisgaard H., Godard P.P. et al. Budesonide /formoterol combination therapy as both maintenance and reliever medication in asthma. Am. J. Respir. Crit Care Med. 2005; 171: 129–136.; Meltzer E.O., Busse W.W., Wenzel S.E. et al. Use of the Asthma Control Questionnaire to predict future risk of asthma exacerbation. J. Allergy Clin. Immunol. 2011; 127:167–172.; https://journal.pulmonology.ru/pulm/article/view/310